Trial intelligence / Profile preview

Erythropoietin for Postoperative Delirium in Elderly Arthroplasty Patients

NCT06178835Phase 4Completed

Sponsor
Yonsei University
Start
Sep 2017
Primary completion
Jul 2019
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 4 trial of erythropoietin in postoperative delirium (POD), sponsored by Yonsei University. Started Sep 2017; status: completed.

02

Drugs

erythropoietin
03

Conditions

postoperative delirium (POD)

Beyond the preview

Go deeper on NCT06178835.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06178835.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call